// App-Quantinova.ai

1379 : Identification of the functional significance of mutations using the novel precision cancer analysis system

Researchers

Presenter

  • Gabi Tarcic

Principal Investigators

  • Nir Peled

  • Zohar Barbash

  • Naama Barabash-Katzir

  • Shlomo Yaakobi

  • Hani Nevo

  • Michael Vidne

  • Mariusz Adamek

  • Mordechai R. Kramer

  • Nikolai Goncharenko

  • Yakov Fellig

  • Karen Meir

  • Keith Mostov

  • Yoram Altschuler

Medical Centers

  • Novellusdx, Jerusalem, Israel

  • Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel

  • Medical University of Silesia, Zabrze, Poland

  • Rabin Medical Center, Beilinson Hospital, Davidoff Center, Petach Tikva, Israel

  • IBBL (Integrated BioBank of Luxembourg), Luxembourg, Luxembourg

  • Hadassah-Hebrew-University-Medical-Cente, Jerusalem, Israel

  • UCSF School of Medicine, San Francisco, CA

Locations

  • Poland

  • Luxembourg

  • United States

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Solid malignancies

  • Post-cardiac arrest syndrome

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Epidermal growth factor receptor

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved